TMCnet News

Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay Technology
[October 18, 2023]

Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay Technology


In light of ViewRay Systems recent announcement that it would close its doors on October 25, 2023, Dr. Suthanthiran, President/Founder of TeamBest Global Companies (TBG) and Best Cure Foundation, is encouraging all to share their thoughts as to how to preserve, upgrade, innovate, and reduce the cost of technology, service, etc., of ViewRay Systems products-for now and in the future.

Suthanthiran has already received numerous inquiries from customers, vendors, and service engineers regarding this matter. He responds to all emails within 24 hours, so please do not hesitate to contact him with concerns and/or suggestions. He wishes to remain in touch with all and feels that it is important that we act on this matter with urgency.

TBG and Suthanthiran are fully committed and hope that ultimately, this technology will be retained in the USA by USA manufacturers.

Nearly 15 year ago, Suthanthiran offered ViewRay CEO and the CEO of another new MR Linac company the opportunity to manufacture and service through TBG's 500,000+ sq. ft. of Global, Sales, Service, R&D, and manufacturing infrastructure as TBG companies have been globally manufacturing and servicing 1000s of high-tech medical types of equipment for more than 70 years.



Despite his offer, neither of the companies took advantage of it. ViewRay has now declared bankruptcy, while the other company has spent over 50 million USD in the past 15 years but is yet to release its product. In an attempt to survive and launch their products, they are waiting to raise more funds.

If acquired, TBG will provide support and services to all existing customers and manufacture, sell, and service new units. Within the next 5 years, TBG plans to introduce upgraded MR Linac Units, which has been on its radar screen for over 15 years. TBG's focus is on expanding its product portfolio through acquisitions and the organic growth of new products.


Earlier this year, one of TBG's companies purchased the assets of Advanced Radiation Therapy/AccuBoost Technology product lines and exhibited at the ABS, AAPM, and AASTRO 2023 meetings. In 2024, TBG companies plan to be manufacturing CT, PET CT, Linac, MRI units, up to 11 Teslas, and tens of thousands of ultrasound systems.


[ Back To TMCnet.com's Homepage ]